## **Core Concept**
Acute Myeloid Leukemia (AML) is a heterogeneous group of diseases characterized by the clonal expansion of myeloid blasts in the bone marrow and peripheral blood. Cytogenetic abnormalities play a crucial role in determining the prognosis of AML patients. The presence of specific chromosomal translocations or deletions can significantly influence the outcome and guide treatment decisions.

## **Why the Correct Answer is Right**
The correct answer, , is associated with the poorest prognosis in AML patients. This abnormality involves a translocation between chromosomes 6 and 9, resulting in the formation of the DEK-NUP214 fusion gene. Studies have shown that patients with this cytogenetic abnormality tend to have a lower complete remission rate, shorter overall survival, and a higher relapse rate compared to other AML subtypes.

## **Why Each Wrong Option is Incorrect**
* **Option A:** is not specifically identified but generally, some translocations like t(8;21) or inv(16) are associated with a relatively favorable prognosis in AML.
* **Option B:** Some abnormalities like are associated with an intermediate prognosis.
* **Option D:** Certain deletions or translocations not specified here might have varying impacts on prognosis but are generally not as poor as .

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that AML patients with have a particularly aggressive disease course and often require more intensive treatment approaches, including allogeneic hematopoietic stem cell transplantation, to achieve optimal outcomes. Recognizing this cytogenetic abnormality is critical for risk stratification and personalized management.

## **Correct Answer:** .